Elevation of Gonadotropin Hormones as Early Predictor Marker for Subfertility among Sudanese Patient with Chronic Kidney Disease Stage-5

  • Ahmad A s
Keywords: CKD, Obesity, Duration of Disease, FSH & LH

Abstract

Background: Chronic kidney disease (CKD) is defined as the decrease of glomerular filtration rate (GFR) that leads to a progressive deterioration of fluid-electrolyte balance and metabolic or endocrinological functions. Furthermore, the relation of CKD with infertility and sexual dysfunction is well-known to affect medical health status as well as physiological status. Additionally, in men with CKD, gonadal dysfunction with elevation of serum gonadotropin concentration is a frequent finding, affecting 26% – 66 % of men with different stages of CKD. The objective of this study is to investigate the serum gonadotropins LH and FSH in patients with CKD.

Methods: This case-control study was conducted at military hospital, police hospital and Kidney transplantation association within six months from November 2017 to April 2018. More importantly, the study was carried out on a total of 80 samples including 40 CKD patients as case and 40 healthy individuals as control group. Finally, serum FSH and LH levels were estimated using ELISA technique and data was analyzed using SPSS software program version 21.

Results: This study has found significant elevation in FSH and LH levels with p-value (0.000, 0.001) respectively in CKD patients compared to control group. Moreover, the study found that FSH level is positively correlated with BMI and duration of disease, while LH level is positively correlated with the duration of disease only.

Conclusion: Our study concluded that patients with CKD have elevated gonadotropins (FSH&LH) levels.

References

1. Alice Schmidt, Anton Lunger, Walter H. Horl. (2002). Sexual hormone abnormalities in male patient with renal failure, Nephrol Dial Transplant,3 (17): 368-371.
2. Diemont WL, Vruggink PA, Meuleman EJ, Doesburg WH, Lemmens WA, Berden JH (2000). Sexual dysfunction after renal replacement therapy, Am J Kidney Dis, 35 (5) p: 845–851.
3. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM.(2005). Association between body mass index and CKD in apparently healthy men, 46 (5) p: 871–880.
4. Hylander, B., Lehtihet, M. (2015). testosterone and gonadotropin but not SHBG vary with CKD stages in young and middle aged men, Basic and Clinical Andrology, 25 (2) p: 9.
5. Iglesias P, Carrero JJ, Diez JJ. (2012). Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options, J Nephrol, 25(1):31–42.
6. KDIGO. (2013). Definition and classification of CKD, Kidney International Supplements, 1 (3) P: 19-62.
7. Kerstin S. Fugl-Meyer, Marie Nilsson, Britta Hylander, Mikael Lehtihet. (2017). Sexual function and testosterone level in men with conservatively treated chronic kidney disease, American Journal of men’s health., 11(4) p:1069-1076
8. Mahboob Lessan-Pezeshki, Shirin Ghazizadeh (2008). sexual and reproductive function in end stage renal disease and effect of kidney transplantation, Asian J Androl, 10(3) p: 441-446.
9. Matthew M. Edey. (2017). male sexual dysfunction and chronic kidney disease, front med, 32(4) https://doi.org/10.3389/fmed.2017.00032.
10. Mihalca R, Fica S, Carol Davila. (2014). the impact of obesity on the male reproductive axis, Journal of Medicine and Life, 2 (7) p: 296-300.
Published
2018-09-01